LATEST

• BUSINESS Sanofi Japan Bets on Beyfortus Track Record with NIP Inclusion in Sight
  November 11, 2026

• BUSINESS Vital KSK’s Medleap Pivots to In-House Drug Filings, Eyes 2029 Launch
  November 10, 2026

• REGULATORY Kyowa Kirin’s Libmeldy Gene Therapy Now in Line for Japan Approval
  November 10, 2026

• COMMENTARY Japan Drug Wholesalers Caught in Multiple Dilemmas as Price Gap Narrows
  November 10, 2026

• REGULATORY Astellas Employee Jailed for Espionage in China Set for December Release
  November 10, 2026

• REGULATORY Nearly 1,200 COVID Vaccine Injury Relief Claims Still Await Review in Japan
  November 10, 2026

• BUSINESS Alfresa, Partners Seal Share Deal to Formalize Biosimilar JV
  November 10, 2026

• REGULATORY LDP League Seeks Drug Pricing Revamp to Support Patches
  November 10, 2026

• BUSINESS Japan Ethical Drug Sales Rise 3.5% in September: Crecon
  November 10, 2026

• BUSINESS Shionogi Grabs Japan Nod for Updated COVID Vaccine
  November 10, 2026

• BUSINESS Kyorin Nabs Japan Rights to Edesa’s ARDS Drug
  November 10, 2026

• REGULATORY Keytruda SC Tops New NHI Listing Round with 75 Billion Yen Sales Outlook
  November 9, 2026

• BUSINESS Lilly, Tanabe Signal Supply Restrictions over Suspected Mounjaro Misuse
  November 9, 2026

• REGULATORY Japan Set to Prioritize Pharma in Growth Strategy Action Plan
  November 9, 2026

• BUSINESS Celltrion to Lift Shipment Curbs on Japan’s 1st Actemra Biosimilar
  November 9, 2026

• BUSINESS AstraZeneca Vows to Back Japanese Innovation with Global Potential
  November 9, 2026

• REGULATORY Japan to Delist 657 Drugs, Including ActHIB and Alofisel
  November 9, 2026

• BUSINESS Nippon Shinyaku Flags Possible IR Data Leak
  November 9, 2026

• BUSINESS Espha Debuts NorLevo Generic in Japan
  November 9, 2026

• BUSINESS Keytruda’s Reign atop Japan Drug Sales Hits 37 Months: Encise
  November 9, 2026

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »